Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Knockdown of NCAPD3 inhibits the tumorigenesis of non-small cell lung cancer by regulation of the PI3K/Akt pathway

Fig. 1

NCAPD3 was overexpressed in NSCLC and associated with worse prognosis. a In Hou lung, Beer lung, and Stearman lung Oncomine datasets, NCAPD3 was upregulated in NSCLC tissues as compared with normal lung tissues. b UALCAN analysis of NCAPD3 expression in TCGA database. c NCAPD3 expression in LUAD and LUSC patients at different cancer stages from UALCAN database. d Kaplan-Meier Plotter website analyzing the correlation between NCAPD3 and survival in NSCLC patients. e Representative images of NCAPD3 expression in LUAD and LUSC tissues based on IHC. f The percentage of NSCLC tissues and para-carcinoma normal tissues exhibiting high ( + + or +++) and low (- or +) expression of NCAPD3. g Kaplan-Meier survival curves for OS in high or low NCAPD3 expression groups; low expression group, n = 75; high expression group, n = 109. (****p < 0.0001)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us